Polypills with or without aspirin for primary prevention of cardiovascular disease

Polypills with or without aspirin for primary prevention of cardiovascular disease

Podrobná bibliografie
Hlavní autoři:	Mant, J, McManus, R
Médium:	Journal article
Jazyk:	English
Vydáno:	Elsevier 2021

Podobné jednotky

Would primary healthcare professionals prescribe a polypill to manage cardiovascular risk? A qualitative interview study
Autor: Virdee, S, a další
Vydáno: (2013)

Cost-effectiveness analysis of use of a polypill versus usual care or best practice for primary prevention in people at high risk of cardiovascular disease
Autor: Jowett, S, a další
Vydáno: (2017)

Polypill for cardiovascular disease prevention.
Autor: Dalton, A
Vydáno: (2013)

Cost-effectiveness analysis of use of a polypill versus usual care or best practice for primary prevention in people at high risk of cardiovascular disease.
Autor: Sue Jowett, a další
Vydáno: (2017-01-01)

The Concept of the Polypill in the Prevention of Cardiovascular Disease
Autor: Brandon Wiley, a další
Vydáno: (2014-04-01)

Use of cardiovascular polypills for the secondary prevention of cerebrovascular disease
Autor: J. Masjuan, a další
Vydáno: (2021-01-01)

Polypills for Primary Prevention of Cardiovascular Disease: A Systematic Review and Meta-Analysis
Autor: Omneya A. Kandil, a další
Vydáno: (2022-04-01)

The feasibility of polypill for cardiovascular disease prevention in Asian Population
Autor: Apichard Sukonthasarn, a další
Vydáno: (2021-03-01)

Missed opportunities in prevention of cardiovascular disease in primary care: a cross-sectional study.
Autor: Sheppard, J, a další
Vydáno: (2014)

Benefits of the Polypill on Medication Adherence in the Primary and Secondary Prevention of Cardiovascular Disease: A Systematic Review
Autor: Lopez-Lopez JP, a další
Vydáno: (2023-09-01)

A Polypill for primary prevention of cardiovascular disease: A feasibility study of the World Health Organization
Autor: Gunaratne Padma S, a další
Vydáno: (2011-01-01)

Medicinal herbs: Potential polypills in cardiovascular diseases
Autor: Samaneh Noroozi, a další
Vydáno: (2021-04-01)

Exercise Rehabilitation in Heart Disease: the real “polypill” for primary and secondary prevention
Autor: Massimo F. Piepoli
Vydáno: (2005-06-01)

The polypill: the solution for prevention of coronary heart disease?
Autor: Hendarto Natadidjaja
Vydáno: (2016-02-01)

Impact of age and sex on primary preventive treatment for cardiovascular disease in the West Midlands, UK: cross sectional study.
Autor: Sheppard, J, a další
Vydáno: (2012)

THE ROLE OF POLYTABLETS (POLYPILL) IN THE TREATMENT OF CHRONIC CARDIOVASCULAR DISEASES
Autor: Николай Владимирович Абрамов, a další
Vydáno: (2024-02-01)

Role of aspirin in primary prevention of cardiovascular disease
Autor: Patrono, C, a další
Vydáno: (2019)

Aspirin overutilization for the primary prevention of cardiovascular disease
Autor: VanWormer JJ, a další
Vydáno: (2014-12-01)

Aspirin for primary prevention of cardiovascular disease in diabetes
Autor: Ying Xing, a další
Vydáno: (2019-07-01)

Polypill versus medication monotherapy in the prevention of cardiovascular diseases in Iran: An economic evaluation study
Autor: Ramin Ravangard, a další
Vydáno: (2024-07-01)

Practical Decision Algorithms for the Use of the Cardiovascular Polypill in Secondary Prevention in Europe
Autor: Lilian Grigorian-Shamagian, a další
Vydáno: (2021-08-01)

Maybe it's time for something a little different? The extent to which current pharmacotherapy practice conforms to national guidelines for primary for cardiovascular disease prevention
Autor: Sheppard, J, a další
Vydáno: (2013)

The use of polypills in cardiovascular disease management: Benefits vs challenges
Autor: Yamaan Adil, a další
Vydáno: (2024-09-01)

Cost-effectiveness of fixed-dose combination pill (Polypill) in primary and secondary prevention of cardiovascular disease: A systematic literature review.
Autor: Reza Jahangiri, a další
Vydáno: (2022-01-01)

Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.
Autor: Hennekens, C, a další
Vydáno: (1989)

A Survey of Availability and Affordability of Polypills for Cardiovascular Disease in Selected Countries
Autor: Gautam Satheesh, a další
Vydáno: (2024-07-01)

Misuse of Aspirin and Associated Factors for the Primary Prevention of Cardiovascular Disease
Autor: Yinong Chen, a další
Vydáno: (2021-09-01)

Redefining the polypill: pros and cons in cardiovascular precision medicine
Autor: Siddharth Birla, a další
Vydáno: (2023-09-01)

Which people should take aspirin for primary prevention of cardiovascular disease?
Autor: Lozano R, a další
Vydáno: (2015-07-01)

Use and Misuse of Aspirin in Primary Cardiovascular Prevention
Autor: Sergio Coccheri
Vydáno: (2017-04-01)

Aspirin for prevention of cancer and cardiovascular disease.
Autor: Rose, P, a další
Vydáno: (2011)

Correction: A Survey of Availability and Affordability of Polypills for Cardiovascular Disease in Selected Countries
Autor: Gautam Satheesh, a další
Vydáno: (2024-08-01)

Role of aspirin in the primary prevention of cardiovascular disease in patients with hyperlipoproteinaemia(a)
Autor: Eleni Giannopoulou, a další
Vydáno: (2024-12-01)

US population qualifying for aspirin use for primary prevention of cardiovascular disease
Autor: Athena L. Huang, a další
Vydáno: (2024-06-01)

US POPULATION QUALIFYING FOR ASPIRIN USE FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE:
Autor: Athena L. Huang, MD, a další
Vydáno: (2023-09-01)

Preventing the progression of climate change: one drug or polypill?
Autor: Hugh Montgomery
Vydáno: (2017-03-01)

Maybe it's time for something a little different? The extent to which current pharmacotherapy practice conforms to national guidelines for stroke and cardiovascular disease prevention
Autor: Sheppard, J, a další
Vydáno: (2013)

Primary prevention of cardiovascular events in diabetes: is there a role for aspirin?
Autor: Price, H, a další
Vydáno: (2009)

Polypill holds promise for people with chronic disease
Autor: Jacqui Wise
Vydáno: (2005-12-01)

Aspirin in the primary prevention of vascular disease Reply
Autor: Baigent, C, a další
Vydáno: (2009)